The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지

Stellate Ganglion Block for the Treatment of Atopic Dermatitis -A case report-

아토피성 피부염 환자의 성상신경절 차단 -증례보고-

  • Kim, Seong-Kon (Department of Anesthesiology, College of Medicine, Kon Kuk University) ;
  • Lee, Kyu-Chang (Department of Anesthesiology, College of Medicine, Kon Kuk University) ;
  • Kang, Po-Sun (Department of Anesthesiology, College of Medicine, Kon Kuk University) ;
  • Woo, Nam-Sik (Department of Anesthesiology, College of Medicine, Kon Kuk University) ;
  • Lee, Ye-Chul (Department of Anesthesiology, College of Medicine, Kon Kuk University)
  • 김성곤 (건국대학교 의과대학 마취과학교실) ;
  • 이규창 (건국대학교 의과대학 마취과학교실) ;
  • 강포순 (건국대학교 의과대학 마취과학교실) ;
  • 우남식 (건국대학교 의과대학 마취과학교실) ;
  • 이예철 (건국대학교 의과대학 마취과학교실)
  • Published : 1995.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Atopic allergy implies a familial tendency to manifest alone or in combination such as asthma, rhinitis, urticaria and atopic dermatitis. The patient with atopic dermatitis shows a variety of humoral and cell-mediated immune dysfunction, including an elevation of serum IgE level, multiple positive immediate skin tests to a variety of antigen. A 30 year old female patient suffering from an atopic dermatitis on face, has been administered a stellate ganglion block(SGB) with a 1% mepivacaine 5cc. She complained of bronchial hyperresponsivness such as cough, soreness, and inspiration difficulty for 5 days following the treatment, so we have reduced 1% mepivacaine dose from 5cc to 3cc. She had no complain of bronchial hyperresponsivenss and the lesion of atopic dermatitis was improved. From our result we conclude that SGB appears to be a good choice for the treatment of the atopic dermatitis and only 1% mepivacaine 3cc is possible in complete SGB.

Keywords